Speakers 2022

Speakers 2022

Olivier ADOTEVI

INSERM UMR1098

Head of INSERM research team "cancer immunotherapy, TIM-C"


RNA AS RAW MATERIELS & THERAPEUTICS

WEDNESDAY, SEPTEMBER 21ST

Professor Olivier ADOTEVI completed his PhD training in immuno-oncology at 2006 at the Pierre & Marie Curie University, Paris and continued with a post-doctorate at Pasteur Institute Paris. To date, he is Professor of Clinical Immunology and thoracic oncology at the Regional Institute of Cancer, university hospital of Besançon. He is the head of INSERM research team " cancer immunotherapy, TIM-C" UMR1098 in Besançon since 2016 and the future director of the whole UMR Right research institute from 2023. The Pr. Adotévi and his team are leading a research program dedicated to the identification of tumor antigens, tumor-reactive CD4 T lymphocytes and in the development of cancer immunotherapy (vaccines, CART cell..) as well as biomarkers identification. In the last few years, its team initiated innovative anticancer vaccine program (UCPVax) in clinic. This vaccine is currently evaluated in several cancers as monotherapy or in combination with immune checkpoint inhibitors.

Main areas of expertise
- Tumor immunology
- Immunomonitoring
- Cancer immunotherapy (Vaccine, Adoptive cell transfer)

Memberships of scientific societies
- Member of SFI (Société française d’immunologie)
- Member of I-REIVAC (Innovative Clinical Research Network In Vaccinology)
- Member of European Society of Medical Oncology

Publications: 123 publications from Web of science, H-Index :23, 1534 Citations.

Find also